|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 318.00 EUR | -0.31% |
|
-2.30% | +0.47% |
| Apr. 16 | VIRBAC : Decent Q1; Clarity on US tariff exposure was a key takeaway |  |
| Apr. 16 | VIRBAC : Stifel still buying after Q1 results | CF |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility (Composite) | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
| 9 | ||||||||
| 15 | ||||||||
| 11 | ||||||||
| 3 | ||||||||
| 6 | ||||||||
| 4 | ||||||||
| 3 | ||||||||
| 3 | ||||||||
| 4 | ||||||||
| 7 | ||||||||
| - | - | - | - | |||||
| 3 | ||||||||
| - | - | |||||||
| 3 | ||||||||
| - | - | |||||||
| - | - | |||||||
| Average | 6 | |||||||
| Weighted average by Cap. | 13 |
- Stock Market
- Equities
- VIRP Stock
- Sector Virbac
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
